Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Yifan Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	18,951	13,040	18,014	15,019	21,745	23,372
Market Cap Growth	5.10%	-27.61%	19.94%	-30.93%	-6.96%	36.83%
Enterprise Value	20,346	14,371	19,400	16,499	22,717	23,710
Last Close Price	15.58	10.63	14.52	12.03	17.31	18.55
PE Ratio	43.22	33.78	-	78.54	78.11	24.14
Forward PE	30.55	20.82	33.59	16.33	32.78	16.68
PS Ratio	3.67	2.53	4.43	3.92	4.93	4.33
PB Ratio	2.19	1.55	2.18	1.64	2.48	2.68
P/TBV Ratio	4.43	3.29	4.67	2.82	4.23	4.70
P/FCF Ratio	116.21	1037.05	-	-	-	59.50
P/OCF Ratio	24.20	20.35	51.68	31.82	72.19	21.09
PEG Ratio	-	0.21	0.21	0.21	0.21	0.21
EV/Sales Ratio	3.94	2.79	4.77	4.30	5.15	4.39
EV/EBITDA Ratio	31.02	22.36	76.48	43.52	50.06	19.91
EV/EBIT Ratio	64.77	44.07	17820.38	96.29	86.48	23.38
EV/FCF Ratio	124.77	1142.95	-	-	-	60.36
Debt / Equity Ratio	0.27	0.27	0.24	0.24	0.26	0.19
Debt / EBITDA Ratio	3.50	3.49	7.34	5.44	4.84	1.39
Debt / FCF Ratio	14.08	182.47	-	-	-	4.23
Asset Turnover	0.42	0.43	0.34	0.31	0.37	0.48
Inventory Turnover	2.44	2.83	2.45	2.65	4.16	4.91
Quick Ratio	0.83	0.84	0.94	1.19	1.13	1.22
Current Ratio	1.31	1.26	1.49	1.68	1.56	1.65
Return on Equity (ROE)	4.62%	3.88%	-10.18%	1.42%	2.77%	11.25%
Return on Assets (ROA)	1.58%	1.71%	0.01%	0.87%	1.38%	5.58%
Return on Capital (ROIC)	1.82%	1.94%	0.01%	0.96%	1.53%	6.30%
Return on Capital Employed (ROCE)	3.30%	3.50%	0.00%	1.70%	2.70%	10.70%
Earnings Yield	2.30%	2.96%	-3.06%	1.27%	1.28%	4.14%
FCF Yield	0.86%	0.10%	-0.86%	-0.47%	-1.24%	1.68%
Dividend Yield	1.29%	1.88%	-	-	-	0.27%
Payout Ratio	71.10%	50.47%	-	45.18%	49.71%	20.86%
Buyback Yield / Dilution	1.09%	1.51%	3.94%	-5.32%	1.26%	-0.40%
Total Shareholder Return	2.38%	3.39%	3.94%	-5.32%	1.26%	-0.13%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.